LB-7. Weight Change in Suppressed People with HIV (PWH) Switched from Either Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) to Tenofovir Alafenamide (TAF)

BACKGROUND: Weight gain in PWH occurred in both naïve and switch studies and is linked to use of integrase inhibitors (INSTIs) with varying associations with nucleoside reverse transcriptase inhibitors (NRTIs). One hypothesis is that gain associated with TAF when switching from TDF is a result of ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Sax, Paul, Althoff, Keri N, Brown, Todd T, Radtchenko, Janna, Diaz Cuervo, Helena, Ramgopal, Moti, Santiago, Steven, Moyle, Graeme, Mounzer, Karam, Elion, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Late Breaker Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776391/
http://dx.doi.org/10.1093/ofid/ofaa515.1904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776391/
http://dx.doi.org/10.1093/ofid/ofaa515.1904

Ejemplares similares